AF
HRMY icon

Allworth Financial’s Harmony Biosciences HRMY Stock Holding History

Allworth Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.8K Buy
1,945
+1,139
+141% +$35.9K ﹤0.01% 2197
2026
Q1 		$22.6K Sell
806
-6
-0.7% -$197 ﹤0.01% 2911
2025
Q4 		$30.4K Buy
812
+602
+287% +$19.8K ﹤0.01% 2531
2025
Q3 		$5.79K Buy
210
+134
+176% +$4.62K ﹤0.01% 3469
2025
Q2 		$2.4K Buy
76
+36
+90% +$1.16K ﹤0.01% 3619
2025
Q1 		$1.18K Hold
40
– – ﹤0.01% 3412
2024
Q4 		$1.55K Hold
40
– – ﹤0.01% 3246
2024
Q3 		$1.6K Hold
40
– – ﹤0.01% 3051
2024
Q2 		$1.28K Sell
40
-16
-29% -$481 ﹤0.01% 3080
2024
Q1 		$1.88K Buy
56
+10
+22% +$321 ﹤0.01% 2828
2023
Q4 		$1.49K Buy
46
+43
+1,433% +$1.2K ﹤0.01% 2808
2023
Q3 		$99 Sell
3
-25
-89% -$868 ﹤0.01% 3345
2023
Q2 		$986 Buy
+28
New +$967 ﹤0.01% 2741
2023
Q1 		– Sell
-300
Closed -$16.5K – 3245
2022
Q4 		$16.5K Sell
300
-8
-3% -$440 ﹤0.01% 1464
2022
Q3 		$14K Buy
+308
New +$15K ﹤0.01% 1446
2022
Q2 		– Sell
-6
Closed – – 2572
2022
Q1 		$0 Buy
+6
New +$245 ﹤0.01% 2228

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's HRMY Position: Q2 2026 in Review

Allworth Financial increased its Harmony Biosciences (HRMY) stake by 141% in Q2 2026, buying an estimated $35.9K and bringing the position to 1,945 shares worth $70.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Allworth Financial first reported a position in HRMY in Q1 2022 and has held it in 16 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Allworth Financial held 1,945 shares of Harmony Biosciences worth $70.8K as of Q2 2026.
  • Allworth Financial bought 1,139 Harmony Biosciences shares in Q2 2026, an estimated $35.9K.
  • Harmony Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2197 holding.
  • Allworth Financial first reported a position in Harmony Biosciences in Q1 2022 and has held it in 16 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.